Evidence map›Paper›PMID 41400551›Full record

ArticleCA: a cancer journal for clinicians

American Cancer Society's Report on the Status of Cancer Disparities in the United States, 2025.

Farhad Islami, Gladys Arias, Dongjun Lee, Daniel Wiese, Jordan Baeker Bispo, K Robin Yabroff, Rebecca L Siegel, Priti Bandi, Nigar Nargis, Alpa V Patel and 11 more

Erratum issuedAbstract read
In one paragraph

Article in CA: a cancer journal for clinicians. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. International journal of molecular sciences · 2026
    Article
  13. Article
  14. Article
  15. Barrier resolution via patient navigation in the context of cancer care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Farhad IslamiSurveilliance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia, USA.ORCID 0000-0002-7357-5994
Gladys AriasAmerican Cancer Society Cancer Action Network, Washington, District of Columbia, USA.
Dongjun LeeSurveilliance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia, USA.
Daniel WieseSurveilliance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia, USA.ORCID 0000-0002-1603-7583
Jordan Baeker BispoSurveilliance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia, USA.ORCID 0000-0002-6801-7971
K Robin YabroffSurveilliance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia, USA.ORCID 0000-0003-0644-5572
Rebecca L SiegelSurveilliance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia, USA.ORCID 0000-0001-5247-8522
Priti BandiSurveilliance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia, USA.ORCID 0000-0003-1169-4231
Nigar NargisSurveilliance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia, USA.ORCID 0000-0003-4501-1398
Alpa V PatelPopulation Science, American Cancer Society, Atlanta, Georgia, USA.ORCID 0000-0001-9997-1218
Paul P ThienprayoonPatient Support, American Cancer Society, Atlanta, Georgia, USA.
Arif H KamalPatient Support, American Cancer Society, Atlanta, Georgia, USA.ORCID 0000-0002-5235-9395
Elvan C DanielsCenter for Innovation in Cancer Research Training, American Cancer Society, Atlanta, Georgia, USA.
Christina M AnnunziataExtramural Discovery Science, American Cancer Society, Atlanta, Georgia, USA.ORCID 0000-0003-2033-6532
Kirsten SloanAmerican Cancer Society Cancer Action Network, Washington, District of Columbia, USA.
Lisa A LacasseAmerican Cancer Society Cancer Action Network, Washington, District of Columbia, USA.
Robert A WinnVirginia Commonwealth University School of Medicine, Richmond, Virginia, USA.ORCID 0000-0001-5948-9291
Otis W BrawleyJohns Hopkins School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-7384-1853
Carmen E GuerraUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-6349-9142
William L DahutChief Scientific Officer, American Cancer Society, Atlanta, Georgia, USA.ORCID 0000-0002-2766-9703
Ahmedin JemalSurveilliance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since 2021, the American Cancer Society has published its biennial report on the status of cancer disparities in the United States. In this 2025 report, the authors provide updated data on disparities in cancer occurrence and outcomes by sex, race, ethnicity, socioeconomic status (SES [educational attainment as a proxy]), and geographic location (including urbanicity of county of residence and congressional district), along with contributors to these disparities, including major cancer risk factors, screening, and select social determinants of health (SDOH) and health-related social needs. The authors found substantial disparities across the cancer continuum, including risk factors, incidence, stage at diagnosis, receipt of care, survival, and mortality for many cancers and in evaluated SDOH by race and ethnicity, educational attainment, and geographic location. During 2019 through 2023, Black and American Indian/Alaska Native populations had the highest cancer mortality rates, both overall and for the leading causes of cancer death. Cancer mortality rates were also consistently higher among adults with lower SES. However, differences in cancer mortality were substantially larger by education than by race, indicating that SES plays a major role in driving racial disparities in cancer mortality. Overall cancer mortality rates were higher in Black adults than in White adults with the same education level by 7%-28% among males and by 2%-43% among females. Within each race, however, overall cancer mortality rates were higher in adults with ≤12 years of education than in those with ≥16 years of education by 143%-192% among males and by 71%-140% among females. Mortality from all cancers combined was 21% higher in nonmetropolitan than in large metropolitan counties, with the greatest differences for lung (45%) and cervical (36%) cancers and the smallest for prostate, female breast, and pancreatic cancers (7%-8%). By congressional district, the highest cancer mortality rates both overall and for lung, colorectal, and breast cancers were largely found in the South and East North-Central division of the Midwest; however, for prostate cancer, there was no distinct geographic pattern. Sociodemographic groups that had higher cancer mortality generally had higher exposure to risk factors, lower health insurance coverage, and limited access to cancer prevention, early detection, and treatment compared with groups that had lower cancer mortality, largely reflecting fundamental disparities in SDOH. Mitigating cancer disparities in the United States requires intersectoral stakeholder engagement, targeted funding, effective policies at the federal, state, and local levels, and broad implementation of evidence-based interventions, such as expanding health insurance coverage, including through strengthening Marketplaces and protecting and expanding access to Medicaid.

Indexed as

Healthcare DisparitiesHealth Status DisparitiesNeoplasmsAdultAmerican Cancer SocietyEthnicityFemaleHumansIncidenceMaleMiddle AgedRisk FactorsSocial Determinants of HealthSocioeconomic FactorsUnited Statescancerdisparityrace/ethnicityruralitysocioeconomic status

Identifiers

PMID41400551
PMCPMC12707308

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.